It was specifically derived from amino acids 176-191
Dual peptide blend: CJC-1295 / Ipamorelin Short-acting peptide combination Studied for growth hormone signaling pathways High purity 99% (HPLC) Pharmaceutical-grade lyophilized form Third-party tested with batch-specific COA Dosage 5mg / 5mg Verified Content Ipamorelin 6.25mg CJC-1295 5.39mg Lot Number 226112 Form Lyophilized powder CAS 863288-34-0 (CJC-1295) 170851-70-4 (Ipamorelin) Molecular Formula C 152 H 252 N 44 O 42 (CJC-1295) C 38 H 49 N 9 O 5 (Ipamorelin) Storage Store cold at 2-8C Each batch is independently third-party tested to meet or exceed labeled purity and content
Orca Bios BLA for Hematologic Malignancy Cell Therapy Orca-T Accepted by FDA With Priority Review October 7, 2025 Orca Bios BLA for Orca-T, an investigational allogeneic cell therapy product intended to treat various hematologic malignancies, including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndromes (MDS), has been accepted by the FDA with priority review
This strength appears frequently because it balances effectiveness, convenience, and routine suitability for daily use
3 You earn 250 Hack points ($5.00) Credited automatically after their purchase clears a short review period